Science Explorer Back to mapMap
Discussion
Topic · Nephrology

Parathyroid Disorders and Treatments

Parathyroid Disorders and Treatments is a research topic within Nephrology. Science Explorer counts 41k research works in it since 1950. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the complex interplay of FGF23, phosphate, calcification, and mineral metabolism in the context of chronic kidney disease. It explores the role of parathyroid hormone, vascular health, and the impact of Klotho deficiency on mineral homeostasis. The cluster also delves into the implications of hyperphosphatemia and calcification on cardiovascular risk in patients with chronic kidney disease.

  • FGF23
  • phosphate
  • calcification
  • chronic kidney disease
  • parathyroid hormone
  • vascular
  • mineral metabolism
  • calcitriol
  • Klotho
  • hyperphosphatemia
Research works
41k
fractional, since 1950
In the world top 10%
4k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+14%
the tick is no change
Largest producer
United States
31% of the 10 largest, 2022-now
Parathyroid Disorders and Treatments

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Parathyroid Disorders and Treatments research?

By volume, the United States and China publish the most (1.8k and 1.5k works in 2022-now).

By volume, 2022-now

  1. 1 United States 1.8k works
  2. 2 China 1.5k works
  3. 3 Japan 506 works
  4. 4 India 404 works
  5. 5 Italy 345 works
  6. 6 United Kingdom 286 works
  7. 7 Türkiye 248 works
  8. 8 Spain 242 works
  9. 9 Germany 228 works
  10. 10 France 227 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 30.5%China: 26.5%Japan: 8.7%India: 7.0%6 others listed: 27.2%31%largest
United States1,768 · 30.5%China1,534 · 26.5%Japan506 · 8.7%India404 · 7.0%6 others listed1,576 · 27.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead Parathyroid Disorders and Treatments research?

By volume in 2022-now, Harvard University publishes the most Parathyroid Disorders and Treatments research, followed by Mayo Clinic and Sichuan University.

By volume, 2022-now

  1. 1 Harvard UniversityUnited States 69 works
  2. 2 Mayo ClinicUnited States 61 works
  3. 3 Sichuan UniversityChina 44 works
  4. 4 Capital Medical UniversityChina 42 works
  5. 5 Shanghai Jiao Tong UniversityChina 40 works
  6. 6 University College LondonUnited Kingdom 40 works
  7. 7 Sun Yat-sen UniversityChina 39 works
  8. 8 Nanjing Medical UniversityChina 39 works
  9. 9 All India Institute of Medical SciencesIndia 36 works
  10. 10 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 36 works

Who are the leading researchers in Parathyroid Disorders and Treatments?

The most-cited researchers publishing on Parathyroid Disorders and Treatments include George Davey Smith, Ali H. Mokdad and Walter Churchill Willett.

  1. 1 George Davey Smith United Kingdom 435k citations
  2. 2 Ali H. Mokdad United States 429k citations
  3. 3 Walter Churchill Willett United States 411k citations
  4. 4 John J.V. McMurray United Kingdom 349k citations
  5. 5 Hermann Brenner Germany 343k citations
  6. 6 Cyrus Cooper United Kingdom 342k citations
  7. 7 Emelia J. Benjamin United States 341k citations
  8. 8 Giuseppe Remuzzi Italy 328k citations
  9. 9 Mika Kivimäki United Kingdom 318k citations
  10. 10 Graeme J. Hankey Australia 316k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Parathyroid Disorders and Treatments?

The most cited paper in Parathyroid Disorders and Treatments is "Mutation of the mouse klotho gene leads to a syndrome resembling ageing." (M Kuro-o, Y Matsumura, H Aizawa et al., 1997), with 66,570 citations. Next come "Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study" (29,690) and "Revised Equations for Estimated GFR From Serum Creatinine in Japan" (6,534).

Most cited papers
#PaperReleasedCitations
1 Mutation of the mouse klotho gene leads to a syndrome resembling ageing. M Kuro-o, Y Matsumura, H Aizawa et al. · PubMed 6 Nov 1997 66,570
2 Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study Ömer Toprak, Hüseyin Kurt, Yasin Sarı et al. · Kidney & Blood Pressure Research Open access 2017 29,690
3 Revised Equations for Estimated GFR From Serum Creatinine in Japan Seiichi Matsuo, Enyu Imai, Masaru Horio et al. · American Journal of Kidney Diseases 2 Apr 2009 6,534
4 Regulation of the Voltage Gated K+ Channel Kv1.3 by Recombinant Human Klotho Protein Ahmad Almilaji, Sabina Honisch, Guilai Liu et al. · Kidney & Blood Pressure Research Open access 2014 5,609
5 The story of phosphorus: Global food security and food for thought Dana Cordell, Jan-Olof Drangert, Stuart B. White · Global Environmental Change 17 Feb 2009 5,213
All 99 most cited papers, with filters and sorting

Where is Parathyroid Disorders and Treatments research done?

The largest centres of Parathyroid Disorders and Treatments research in 2022-now are Beijing (China), Tokyo (Japan), Guangzhou (China) and Shanghai (China). Among places with at least 20 works in it, it is an unusually large share of all research in Birmingham.

Largest cities, 2022-now

  1. 1 BeijingChina 211 works
  2. 2 TokyoJapan 115 works
  3. 3 GuangzhouChina 114 works
  4. 4 ShanghaiChina 111 works
  5. 5 LondonUnited Kingdom 94 works
  6. 6 SeoulSouth Korea 93 works
  7. 7 New YorkUnited States 87 works
  8. 8 São PauloBrazil 84 works
  9. 9 ParisFrance 79 works
  10. 10 BostonUnited States 76 works

Where it is the local speciality

  1. BirminghamUS · 32.0 works7.0×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Parathyroid Disorders and Treatments than the world average.

See Parathyroid Disorders and Treatments on the map

Where is the best place to study Parathyroid Disorders and Treatments?

Among universities, judged by research, Harvard University, University College London and Southern Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 19.71%fractional works in this field (log) →share of work in the world top 10% →Southern Medical Uni…Karolinska InstitutetUniversity College L…Harvard University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 78.718.5%3.0×69 +1.1%
2University College LondonUnited Kingdom 71.318.9%3.4×40 +45.0%
3Southern Medical UniversityChina 67.921.0%6.4×29 +79.7%
4Karolinska InstitutetSweden 66.919.4%5.3×22 +9.6%
5University of Alabama at BirminghamUnited States 64.217.5%8.4×30 +33.0%
6Sun Yat-sen UniversityChina 63.918.4%2.6×39 +36.2%
7Nanchang UniversityChina 62.728.7%2.5×14 +18.1%
8Johns Hopkins UniversityUnited States 62.213.4%2.9×32 +13.8%
9Sichuan UniversityChina 61.316.3%2.6×44 +57.9%
10Jiangsu UniversityChina 60.125.0%2.8×16 +118.3%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Parathyroid Disorders and Treatments, country by country

Is Parathyroid Disorders and Treatments research growing?

Output in 2022-2025 was 14% higher than in 2018-2021, peaking in 2025. The fastest-growing topics are Parathyroid Disorders and Treatments.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Parathyroid Disorders and Treatments as a percentage of every work published that year, 0.033% in 2024.

still counting0.020%0.040%0.060%Parathyroid Disorders and Treatments0.037% in 202519801990200020102020

Fractional works of Parathyroid Disorders and Treatments over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Parathyroid Disorders and Treatments9.8% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Parathyroid Disorders and Treatments. Posts are plain text and can be reported.